Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Ala

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of Neurology|September 1, 1994
The clinical correlates of high-titer IgG anti-GM1 antibodiesT A Ala, W H Frey
Alzheimer Disease and Associated Disorders|January 1, 1995
Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer disease. A clinicopathologic studyT A Ala, W H Frey
Receptors & Signal Transduction|January 1, 1997
Inhibition of antagonist binding to human brain muscarinic receptor by vanadium compoundsH Venters, T A Ala, W H Frey
Archives of Neurology|October 1, 1996
Posterior cortical atrophy: neuropathological correlationsT A Ala, W H Frey, H B Clark
Neurology|May 1, 1987
Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tanglesC R Emory, T A Ala, W H Frey
Neurology|February 26, 2000
Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's diseaseT A Ala, G O Beh, W H Frey
Journal of Neuroimmunology|August 1, 1994
Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptomsT A Ala, P A Perfetti, W H Frey
Acta Neuropathologica|May 11, 2000
Inconsistency between severe substantia nigra degeneration with Lewy bodies and clinical parkinsonism in dementia patients: a cliniconeuropathological studyT A Ala, K H Yang, J H Sung, et al.
Brain Research|September 18, 1995
Quantitative analysis of the olfactory pathway for drug delivery to the brainR G Thorne, C R Emory, T A Ala, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 9, 1999
Clinical parkinsonism in dementia patients with substantia nigra Lewy bodiesT A Ala, K H Yang, J H Sung, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of Neurology|September 1, 1994
The clinical correlates of high-titer IgG anti-GM1 antibodiesT A Ala, W H Frey
Alzheimer Disease and Associated Disorders|January 1, 1995
Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer disease. A clinicopathologic studyT A Ala, W H Frey
Receptors & Signal Transduction|January 1, 1997
Inhibition of antagonist binding to human brain muscarinic receptor by vanadium compoundsH Venters, T A Ala, W H Frey
Archives of Neurology|October 1, 1996
Posterior cortical atrophy: neuropathological correlationsT A Ala, W H Frey, H B Clark
Neurology|May 1, 1987
Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tanglesC R Emory, T A Ala, W H Frey
Neurology|February 26, 2000
Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's diseaseT A Ala, G O Beh, W H Frey
Journal of Neuroimmunology|August 1, 1994
Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptomsT A Ala, P A Perfetti, W H Frey
Acta Neuropathologica|May 11, 2000
Inconsistency between severe substantia nigra degeneration with Lewy bodies and clinical parkinsonism in dementia patients: a cliniconeuropathological studyT A Ala, K H Yang, J H Sung, et al.
Brain Research|September 18, 1995
Quantitative analysis of the olfactory pathway for drug delivery to the brainR G Thorne, C R Emory, T A Ala, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 9, 1999
Clinical parkinsonism in dementia patients with substantia nigra Lewy bodiesT A Ala, K H Yang, J H Sung, et al.
Pageof 2